RJA
MXIM

Raymond James & Associates’s Maxim Integrated Products MXIM Stock Holding History

Raymond James & Associates’s Portfolio MXIM Stock Details MXIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-40,200
Closed -$6K – 3521
2017
Q2 		$6K Sell
40,200
-124,900
-76% -$5.74M ﹤0.01% 3316
2017
Q1 		$224K Buy
+165,100
New +$7.23M ﹤0.01% 2864
2016
Q4 		– Sell
-165,400
Closed -$157K – 3397
2016
Q3 		$157K Buy
+165,400
New +$6.52M ﹤0.01% 2924

Other funds holding MXIM

CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return
RP
Rowlandmiller & Partners Atlanta, Georgia $549M AUM 36.2% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Raymond James & Associates's MXIM Position: Q3 2021 in Review

Raymond James & Associates sold out of Maxim Integrated Products (MXIM) in Q3 2021, closing a stake of 51,456 shares — an estimated $5.42M sold.

Raymond James & Associates first reported a position in MXIM in Q2 2013 and held it in 33 quarters. The position peaked at $27.6M in Q2 2020. 3 funds tracked by Wall St. Rank hold MXIM as of Q3 2021.

  • Raymond James & Associates reported no remaining Maxim Integrated Products position as of Q3 2021 after selling out during the quarter.
  • Raymond James & Associates sold 51,456 Maxim Integrated Products shares in Q3 2021, an estimated $5.42M.
  • Raymond James & Associates first reported a position in Maxim Integrated Products in Q2 2013 and held it in 33 quarters.
  • Raymond James & Associates's Maxim Integrated Products position peaked at $27.6M in Q2 2020.
  • 3 funds tracked by Wall St. Rank held Maxim Integrated Products as of Q3 2021.

Based on Raymond James & Associates's 13F filing for Q3 2021, filed 2 Nov 2021.